Skip to main content
Back to AI NewsNews

US Government, Google, Meta Back $1.8 Billion AI Biology Push

The US government, Google, and Meta are joining Chan Zuckerberg Biohub in a $1.8 billion initiative to build open biology datasets for AI.

cueball EditorialWednesday, 7 October 2026 3 min read

What Happened

The United States government, Alphabet's Google, and Meta Platforms announced Tuesday they are joining the Chan Zuckerberg Biohub, a nonprofit backed by Meta chief executive Mark Zuckerberg and his wife Priscilla Chan, in a $1.8 billion effort to build open biological datasets for training artificial intelligence models. The initiative aims to make large-scale biology data broadly accessible to researchers developing AI systems for health and life sciences applications.

Who Is Involved

The Chan Zuckerberg Biohub is a San Francisco-based nonprofit research organization established in 2016 through a founding commitment from Zuckerberg and Chan. The new coalition adds two of the world's largest technology companies alongside federal government participation, though the specific US agencies involved were not detailed in the wire reports available at publication time. Alphabet, the parent company of Google, and Meta Platforms are among the largest corporate investors in AI infrastructure globally.

What the Initiative Covers

According to Reuters, the program is focused on constructing open datasets specifically designed to train AI models on biological information. The $1.8 billion figure represents the combined scale of commitments from the participating parties. Open datasets in AI development refer to data made available for use without proprietary restrictions, allowing researchers outside the funding organizations to access and apply the information. The biology and health sector has been identified by multiple technology and pharmaceutical companies as a primary application area for large-scale AI systems.

Background

The announcement follows a broader pattern of public-private investment in AI-ready scientific data. Major technology companies including Google and Microsoft have each announced separate AI health and biology programs in recent years. Federal agencies including the National Institutes of Health have also funded data infrastructure efforts, though the specific government entities participating in this Biohub initiative were not confirmed in reports reviewed for this article.

Open biological data initiatives have gained attention as AI developers identify data availability as a key constraint on model performance in scientific domains. Biology presents particular challenges because relevant data is distributed across research institutions, hospitals, and private companies, and is often not formatted for use in AI training pipelines.

What the Numbers Say

At $1.8 billion, the initiative represents one of the larger publicly announced commitments to open scientific data infrastructure. The figure encompasses contributions from all participating parties combined. Reuters reported the involvement of the US government alongside Alphabet and Meta, though the precise allocation of funding among participants was not available in published reports at the time of writing.

Context on Biohub

The Chan Zuckerberg Biohub operates as an independent nonprofit separate from Meta Platforms, though it shares its founding donors with the Chan Zuckerberg Initiative, the limited liability company through which Zuckerberg and Chan manage philanthropic commitments. Biohub conducts and funds scientific research across its network of affiliated institutions, primarily in the San Francisco Bay Area. The organization has previously funded work in cell biology, infectious disease, and biomedical imaging.

What Happens Next

Reuters reported that the dataset construction effort is moving forward under the coalition structure announced Tuesday, with further details on participating government agencies and data release timelines expected to be disclosed as the program advances.

Get our editors' take on what it all means. Read the Editor's Blog →